Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation

Post-treatment exercise programme improves survival for stage II/III colon cancer

MS-553 shows promise in treating chronic lymphocytic leukaemia

Key insights on breast cancer in Cape Verde

Addressing cancer control challenges in Africa

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL

Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC

Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL

Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B-ALL